Short Interest in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Increases By 208.3%

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 3,700 shares, a growth of 208.3% from the September 30th total of 1,200 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily volume of 10,500 shares, the short-interest ratio is currently 0.4 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV raised its position in shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) by 289.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 67,000 shares of the medical device company’s stock after purchasing an additional 49,800 shares during the quarter. Azzad Asset Management Inc. ADV owned 0.19% of STRATA Skin Sciences worth $25,000 as of its most recent SEC filing. 32.43% of the stock is currently owned by hedge funds and other institutional investors.

STRATA Skin Sciences Stock Performance

Shares of SSKN traded down $0.01 on Friday, reaching $3.11. The company’s stock had a trading volume of 738 shares, compared to its average volume of 11,832. The stock’s 50 day simple moving average is $3.01 and its two-hundred day simple moving average is $3.46. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.14 and a quick ratio of 0.92. The stock has a market capitalization of $12.97 million, a P/E ratio of -1.28 and a beta of 1.35. STRATA Skin Sciences has a 12-month low of $2.51 and a 12-month high of $6.96.

STRATA Skin Sciences (NASDAQ:SSKN) last issued its quarterly earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share for the quarter. STRATA Skin Sciences had a negative return on equity of 50.45% and a negative net margin of 25.40%. The business had revenue of $8.44 million for the quarter. Research analysts forecast that STRATA Skin Sciences will post -1 earnings per share for the current fiscal year.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.